Junpei Soeda

Shinshu University Hospital

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Collaborators (4)

Lindsey Ann Edwards

King’s College London

UNITED KINGDOM

Marc Peeters

University of Antwerp

Kosei Hasegawa

Saitama Medical University

Shinichi Komiyama

Toho University Faculty of Medicine

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Junpei Soeda

Research Interests

Explore related searches

Contact this professor

Articles (14)

Collaborators (4)

Lindsey Ann Edwards

Marc Peeters

Kosei Hasegawa

Shinichi Komiyama

Make your next move.

Junpei Soeda

Research Interests

Explore related searches

Contact this professor

Articles (14)

A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness

A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis

Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis

The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis

The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis

Distribution and Detectability of<i> EGFR</i> Exon 20 Insertion Variants in NSCLC

Early tumor shrinkage and depth of response with first-line panitumumab or bevacizumab and mFOLFOX treatment in PARADIGM

Phase 2 single-arm study on the efficacy and safety of niraparib in japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer

Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study

Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor

Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726] (Biochemistry and Biophysics Reports (2020) 21, (S2405580819302675), (10.1016/j.bbrep.2020.100726))

Collaborators (4)

Lindsey Ann Edwards

Marc Peeters

Kosei Hasegawa

Shinichi Komiyama

Make your next move.